Accenture Q4 FY26 Earnings Analysis: Why is ACN Stock Rising?

Aadi Bihani Image

Aadi Bihani

Last updated:
14 min read
Accenture Q4 Earnings Analysis
Table Of Contents
  • Accenture Q4 FY2026 Earnings: What Beat Expectations?
  • Why Is ACN Stock Rising After The Q4 Earnings Report?
  • What Went Right for Accenture? Follow the Work, Not the AI Slogans
  • Accenture FY27 Guidance: Stronger Than Feared, But the Organic-Growth Bridge is Missing
  • Why The 46% EPS Headline of Accenture Needs A Second Look
  • The Cash Test for Accenture: Good Cash Generation, Expensive Expansion
  • ACN's Valuation After Today’s Jump
  • Accenture Stock After Earnings: Three Ways to Read the Next Update
  • Author's View: What Did Accenture Prove?

In June, Accenture beat profit expectations and its stock sank because investors feared the next wave of work was drying up. Today, the script flipped. Accenture reported $22.17 billion of new bookings and its fastest quarterly local-currency revenue growth of fiscal 2026, sending ACN shares about 18% higher in the pre-market trading before the US market opened. 

The hard question now is whether the business improved enough to deserve the new price, not merely whether the earnings report was good.

Let's break down the earnings surprise, the CEO's message and the fiscal 2027 outlook of Accenture. Then we'll test what the share-price jump assumes about Accenture's underlying growth and the cash it keeps.

Accenture Q4 FY2026 Earnings: What Beat Expectations?

Accenture's fiscal fourth quarter ended on August 31, 2026. The company reported on October 1. Here is the scorecard against the Visible Alpha estimates available before the release. The prior-year EPS figure is adjusted so that last year's restructuring charge does not distort the comparison.

MeasureQ4 FY25 comparableAnalyst expectation for Q4 FY26Q4 FY26 actualSurprise versus expectation
Revenue$17.60B$18.04B$18.68B+$0.64B, about 3.5%
Earnings per share$3.03 adjusted$3.19$3.29 GAAP+$0.10, about 3.1%
New bookings$21.31B$19.9B$22.17B+$2.27B, about 11.4%
Revenue growth, local currency4.5%Company guided to 1%-5%7%2 points above the guide's top end

Revenue also exceeded Accenture's own $18.40 billion upper target by about $280 million, even though currency was a slightly greater drag than the company had assumed. Full-year revenue reached $74.18 billion, up 5% in local currency against the 3-4% range management had given in June. Full-year adjusted EPS was $13.97, above the previous 13.78-13.90 outlook.

The biggest surprise was future work. Analysts had expected bookings to fall from $21.31 billion a year ago to $19.9 billion. Instead they grew to $22.17 billion. Bookings divided by revenue, called book-to-bill, came to roughly 1.19, which the company rounds to 1.2. 

In plain English, Accenture signed about $1.19 of new work for each $1 of work it delivered and recorded as revenue this quarter. It is a useful demand signal, though a large contract can be delivered over several years.

Why Is ACN Stock Rising After The Q4 Earnings Report?

The share-price reaction makes more sense alongside June. Back then, Q3 consulting revenue grew just 1% in local currency, bookings were $19.32 billion, and management narrowed its FY26 growth outlook. Strong current profit could not answer the question investors cared about: would clients commit to more work next year? Here’s our analysis of June's share-price drop.

The concern after JuneWhat October's release actually showedWhat it does not settle
Consulting demand was slowingConsulting revenue grew 7% in local currency in Q4, versus 1% in Q3One strong quarter does not set FY27's organic growth rate
The order pipeline looked softBookings rose from $19.32B in Q3 to $22.17B in Q4; FY26 bookings totaled $84.54BTiming of large contracts can move quarterly totals
FY26 guidance had narrowedFY26 local-currency revenue growth finished at 5%, above June's 3%-4% guideFY27 guidance is 3%-6%, including acquired businesses

Sources: Accenture Q4 release, Accenture Q3 release. Q3-to-Q4 figures compare consecutive quarters and are not seasonally adjusted.

In our September 30 preview, adding the first three quarters' reported bookings to the $19.9 billion Q4 analyst estimate suggested roughly $82.2 billion of bookings for FY26. The actual total was $84.54 billion, about $2.3 billion above that rough pre-report calculation. The bookings surprise, rather than the smaller EPS surprise, changed the demand story.

ACN closed September 30 at $183.37, up 3.53% that day. A subsequent premarket snapshot showing a 17.95% rise implies roughly $216.28 per share from that close. Yahoo Finance showed a nearby quote around 216-217 at 7:20 a.m. ET. That is an early premarket indication, not an October 1 closing price.

The move also exceeded the roughly 8% end-of-week swing that options prices had implied before the report, according to Investopedia.

What Went Right for Accenture? Follow the Work, Not the AI Slogans

Consulting and managed services each grew 7% in local currency in Q4. Every geographic market also recorded 7% local-currency growth. Across industries, Communications, Media & Technology grew 11%, Health & Public Service 9%, and Products 4%. This breadth is more convincing than a single outsized client contract.

The two types of work tell slightly different stories. Consulting revenue was $9.28 billion and consulting bookings $9.40 billion, or roughly 1.0 book-to-bill. Managed services revenue was $9.40 billion, with $12.77 billion of bookings, or roughly 1.4 book-to-bill. The consulting rebound shows projects are being delivered faster; the stronger managed-services order ratio provides more of the visible pipeline. Neither ratio guarantees the same pace of revenue next quarter.

There is a wrinkle inside the $22.17 billion bookings headline: versus Q3, consulting bookings eased from about $10.3 billion to $9.4 billion, while managed-services bookings climbed from about $9.1 billion to $12.77 billion. The sequential increase in total bookings therefore came from the longer-cycle managed-services side. Those contracts can be lumpy, and consulting bookings still grew from $8.87 billion a year ago, but this split is why we want the 7% consulting revenue gain to persist rather than assuming Q4 established a new project pipeline on its own.

CEO Julie Sweet said the company exceeded its Q4 revenue guidance, delivered broad growth and returned a record $11.5 billion to shareholders in FY26. She also highlighted a record 141 quarterly client bookings of at least $100 million, compared with 129 in FY25. That 141 is the full-year tally, not 141 separate Q4 deals: Accenture had reported 104 year to date through Q3, implying 37 additional client-quarter instances in Q4. The count can include a client in more than one quarter, and it does not tell us how many were AI contracts.

That distinction matters. Accenture stopped publishing separate advanced-AI revenue and booking figures after Q1 FY26, saying AI had become embedded in broader client programs. We cannot take the $22.17 billion bookings total and call it an AI bookings number. The stronger evidence is that total work signed, total work delivered and consulting growth improved together. It supports a case that Accenture is finding paid work around technology change; it is not a clean measurement of how much AI revenue replaced older, more labor-intensive work.

Between reports, Accenture issued about $5 billion of notes in July, expanded its cybersecurity portfolio through acquisitions and announced new Google Cloud and Anthropic initiatives in September. These moves help explain the FY27 strategy and its funding costs; transactions completed after August 31 did not create Q4 revenue. In June, management also said some large managed-services opportunities had shifted into FY27, not Q4. The Q4 bookings beat deserves credit on its own terms, without assuming those exact postponed contracts came back.

Accenture FY27 Guidance: Stronger Than Feared, But the Organic-Growth Bridge is Missing

The new outlook is the heart of this report. Accenture expects 3-6% local-currency revenue growth for the fiscal year ending August 2027, with a roughly flat full-year currency effect. The 4.5% midpoint is slightly above the approximately 4% growth expectation reported by Investor's Business Daily ahead of the release. But management has not yet supplied an updated organic-growth bridge in the Q4 release.

FY27 itemCompany's new outlookA useful comparison
Q1 revenue18.95B-19.60B; 2%-6% growth in local currencyQ4 just grew 7% in local currency
Full-year revenue growth3%-6% in local currency; FX assumed flatFY26 finished at 5% in local currency
Full-year revenue in dollars, illustrativeAbout 76.4B-78.6BOur calculation: $74.18B FY26 base × 1.03 to 1.06, assuming FX is flat
Operating margin15.9%-16.1%FY26 adjusted margin was 15.8%; a comparable 0.1-0.3 point expansion
Diluted EPS14.39-14.81About 3%-6% above FY26 adjusted EPS of $13.97
Free cash flow11.0B-11.8BFY26 actual was $11.62B; $11.4B midpoint is about 1.9% lower
Cash returned to shareholdersAt least $9.5BFY26 actual was $11.5B

Source: Accenture Q4 release. Dollar revenue translation is our illustration, not company dollar guidance. Accenture also raised its quarterly dividend by 5%, to $1.71 per share. The lower end of the Q1 guide shows management is not simply projecting Q4's 7% local-currency pace into the new year.

Here is our most important adjustment. Organic growth is growth from existing operations, excluding the revenue added by acquisitions. Imagine a shop chain adding a new location: total sales rise, but you still need to know whether the original shops are attracting more customers. In June, CFO Angie Park said Accenture expected to enter FY27 with slightly less than two percentage points of inorganic contribution from its deals. If we use 1.8 points as an illustration, the headline FY27 range translates like this:

Hypothetical FY27 local-currency growthAssumed acquisition contributionIllustrative existing-business growthRevenue added on FY26's $74.18B base
3.0%1.8 points1.2%About $2.23B total
4.5% midpoint1.8 points2.7%About $3.34B total
6.0%1.8 points4.2%About $4.45B total

These are our scenarios, not Accenture's organic-growth guidance. The timing and revenue mix of acquisitions can change, and management's June comment described the position entering FY27, not necessarily its contribution to the entire fiscal year. Still, the math exposes the open question: a 4.5% headline midpoint could mean roughly 2.7% growth in the existing business under this assumption. FY26 grew 5% in local currency overall; the company previously expected around 1.5 points of inorganic growth, which would put a similarly rough FY26 organic reading near 3.5%. On those assumptions, the FY27 midpoint would be a step down in underlying growth despite Q4's strong finish. Management needs to update the bridge on the call or at its October 14 Investor Day.

Why The 46% EPS Headline of Accenture Needs A Second Look

Accenture's Q4 GAAP EPS rose 46%, from $2.25 to $3.29. Last year's quarter included a $615 million restructuring charge. Remove its impact and the comparable Q4 FY25 EPS base was $3.03; growth to $3.29 becomes about 9%. Q4's GAAP operating margin rose from 11.6% to 15.3%, but against last year's 15.1% adjusted margin, the underlying expansion was 0.2 percentage point. This is still progress. It is a different story from a 46% jump in repeatable per-share earning power.

Accenture itself supplied an unusually helpful EPS bridge:

Change from Q4 FY25 adjusted EPSPer-share effect
Higher revenue and operating results+$0.22
Lower share count+$0.13
Lower tax rate+$0.03
Noncontrolling interests and lower nonoperating income, net−$0.12
Total change: $3.03 to $3.29+$0.26

Source: Accenture Q4 release. Roughly half of the net $0.26 per-share gain came from the lower share count ($0.13), helped by repurchases. This does not negate the $0.22 operating improvement. It tells investors not to describe every cent of EPS growth as a new AI profit stream. Likewise, FY27's guided 15.9%-16.1% operating margin should be compared with FY26's 15.8% adjusted margin, not only its 15.4% GAAP margin, which included optimization costs.

The Cash Test for Accenture: Good Cash Generation, Expensive Expansion

For the full year, free cash flow rose from $10.87 billion to $11.62 billion, a genuinely strong result. But Q4 alone generated $2.85 billion, roughly 25% below the $3.81 billion from a year earlier, and days sales outstanding rose from 47 to 50 days. One quarter can reflect the timing of client payments; it is a reason to watch collections, not proof of a permanent problem. FY27's free cash flow midpoint of $11.4 billion does not yet show the same growth as guided EPS.

There is a second cash question, especially given the acquisitions discussed in our preview. Accenture's reported free cash flow deducts capital expenditure but does not deduct purchases of businesses and investments. Those purchases totaled $4.94 billion in FY26. Subtract them as a separate analytical check and the $11.62 billion of free cash flow becomes approximately $6.68 billion after those purchases, before dividends and repurchases. That is our acquisition-inclusive cash calculation, not a company-reported free cash flow metric.

FY26 cash and balance-sheet checkAmount
Reported free cash flow$11.62B
Less: purchases of businesses and investments, net of acquired cash$4.94B
Cash after those purchases, our calculation$6.68B
Dividends and share repurchases/redemptions$11.5B
Difference between the last two linesAbout $4.82B
Cash at August 31$12.83B
Current borrowings plus long-term debt at August 31About $10.11B

Source: Accenture Q4 release. The company raised roughly $4.98 billion of net debt financing during the year, and net cash (cash minus these debt balances) fell from roughly $6.33 billion a year earlier to $2.72 billion. Cash is fungible, so the table does not prove any specific repurchase was financed with borrowing. It shows why free cash flow, acquisition spending, debt and shareholder distributions need to be read on the same page. The business has ample cash, but its growth and capital-return plans are not costless.

ACN's Valuation After Today’s Jump

At the September 30 close of $183.37, ACN was priced at about 12.6 times the midpoint of FY27's 14.39-14.81 EPS guide. A 17.95% premarket rise implies about $216.28 a share and roughly 14.8 times that same $14.60 EPS midpoint. The earnings forecast has not changed between those two calculations; investors are offering a higher multiple because they now see less risk in the business.

Illustrative price pointPrice ÷ $14.60 FY27 EPS midpoint$11.4B FY27 FCF midpoint ÷ approximate equity value
September 30 close: $183.3712.6×About 10.4%
Early premarket, calculated from +17.95%: $216.2814.8×About 8.8%

Our calculations use Accenture's roughly 596 million shares outstanding at August 31 and a fixed FY27 EPS and cash-flow midpoint. The cash yield is an equity free-cash-flow yield, not a promised shareholder return; it also excludes future acquisition spending. Shares outstanding, the actual trading price and realized results can all change. On that same approximate share count, a 17.95% jump adds about $19.6 billion to the company's equity value versus the September 30 close. This is a change in what investors will pay for the future, not $19.6 billion of new cash produced in Q4.

Our view: the Q4 operating turn is real, but the premarket price has already rewarded it. The still-respectable illustrative cash yield makes ACN worth studying after the jump; the missing FY27 organic bridge and acquisition-inclusive cash picture make an impulsive, full-sized entry harder to defend.

Accenture Stock After Earnings: Three Ways to Read the Next Update

The release answers what happened in Q4. The call and subsequent quarters will show whether that pace lasts. Here is the decision framework we would use at the price available when making a decision, not at an assumed premarket print.

What new evidence appears?How we would interpret itA practical response for a potential or existing investor
Stronger case: Management confirms FY27 existing-business growth around 3%-4% or better, consulting stays healthy, large bookings convert to revenue, and cash after deal spending improvesThe Q4 turn is extending into the core business; a higher valuation has firmer supportA potential investor can consider a measured initial allocation, with room to add only if later results confirm the thesis. An existing investor can test whether exposure still fits the new valuation.
Mixed case: Headline growth hits the 4.5% guide midpoint but roughly two points come from acquisitions; FY27 FCF stays near $11.4BThe company is sound, but the current valuation may already reflect much of the recoveryWe would wait for the organic bridge and Q1 execution before committing a large fresh amount. Reassess the price against cash generation rather than extrapolating the premarket rise.
Weakening case: Consulting growth slips back, book-to-bill drops below 1 for more than a quarter, or acquisitions consume cash without lifting organic growthThe order pipeline and funding costs no longer support the same earnings narrativeRequire a much larger valuation cushion and clearer evidence of a recovery. Existing investors should revisit the growth and cash assumptions behind their exposure.

The thresholds in this table are our analytical tests, not company targets. A single large outsourcing contract can move book-to-bill; compare several quarters before deciding demand has permanently changed. The October 1 call should also clarify US federal spending, the previously postponed large deals, pricing of AI-enabled work and the expected acquisition contribution to FY27. Until those details are public, nobody should invent management answers to them.

Author's View: What Did Accenture Prove?

Accenture has earned a serious reassessment. The bookings beat was more important than the ten-cent EPS beat, and the jump from 1% to 7% local-currency consulting growth is the cleanest sign that client work improved. Its FY26 revenue and EPS finished above management's latest targets. These are meaningful facts, not just a relief rally story.

I would still separate three receipts before treating the AI debate as settled: new orders (bookings), work delivered by the existing business (organic revenue), and cash left after building that business (including acquisitions). 

Q4 passed the first receipt and improved the second operationally. The FY27 organic bridge and acquisition-inclusive cash test remain open. At roughly $216 indicated before the bell, the stock no longer comes with September 30's valuation cushion. For a potential investor, the question is less “Did Accenture have a good quarter?” than “Will the next year justify paying for a recovery today?”

Share: